Systolic Pressure Efficacy and Safety Trial of Alagebrium (SPECTRA)
Clinical trial NCT00089713 · TERMINATED
Trial details
- NCT number
- NCT00089713
- Sponsor
- Synvista Therapeutics, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-03-01
- Enrollment
- 392
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.